Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiro Fukuo is active.

Publication


Featured researches published by Yoshihiro Fukuo.


Clinical Drug Investigation | 1997

Dual Effects of Bezafibrate on Lipid Metabolism and Hepatobiliary Enzymes

Yoshihiro Fukuo; Shinichi Takagi; Harumi Akaishi; Reibun Kanbara; Akiro Terashi

SummaryWe encountered a patient with Sjögren’s syndrome showing high levels of serum alkaline phosphatase (ALP) and gamma glutamyl transpeptidase (γ-GTP) whose hepatobiliary function was considerably improved by treatment with bezafibrate. In order to clarify the mechanism by which bezafibrate decreases these hepatobiliary enzymes, 400mg of this drug was administered daily to 26 patients with hyperlipidaemia for 7 months, and biochemical and haematological parameters were determined. Serum ALP decreased significantly (p < 0.001) from the baseline level of 174.5 IU/L to 116.7 IU/L (−26.5%), and γ-GTP from 64.4 IU/L to 34.4 IU/L (−29.5%). Other biochemical and haematological parameters remained unchanged. We compared bezafibrate-induced changes in serum lipids with those in serum ALP and γ-GTP. There was a slight correlation between γ-GTP and triglyceride levels, but not between ALP and total cholesterol, triglycerides or high density lipoprotein cholesterol. A close correlation was observed between ALP and γ-GTP (r = 0.81, p < 0.001).From these results, it was suggested that bezafibrate acts on the hepatobiliary enzymes independently of its effect on lipid metabolism.


Nosotchu | 1992

Apolipoprotein E phenotype frequencies in the cerebral infarction.

Hiroshi Araki; Yoshihiro Fukuo; Yoji Kobayashi; Mikio Nagashima; Akiro Terashi

脳梗塞発症と関連し, 高脂血症は重要なrisk factorのひとつとして, 広く認められているがその詳細はいまだ明らかでない.脳梗塞患者ではHDL中のapoE濃度は対照よりも低下していることが報告され, apoEの動脈硬化における役割が注目されてきている.ApoEはVLDLより分離され, 229個のアミノ酸からなるpolypeptideで遺伝的多形性をもっている.三つの対立遺伝子e2, e3, e4によりcodeされ, apoE2, E3, E4が存在する.これらの組み合わせによりE2/2, E3/2, E3/3, E4/2, E4/3, E4/4の6種類の表現型となる.我々はapo Ephenotypeと脳梗塞との関係を皮質枝梗塞と穿通枝梗塞に分け検討し, また, 血清脂質 (Total cholesterol : T-cho, Triglyceride : T-G, High density lipoprotein cholesterol : HDLcho) 及びapolipoprotein (A-I, A-II, B, C-II, C-III, E) との関連についても検討した.慢性期脳梗塞患者において, 対照と比べ, E3/2が高頻度であった.また, 血清脂質において, 皮質枝梗塞ではT-choの濃度が高い傾向があり, 特にE3/2typeで顕著であった.Apolipoproteinにおいては, 有意な上昇は認めなかった.一方, 穿通枝梗塞においては有意な脂質の上昇は認めなかった.このことはapoEphenotypeの独立の因子としての可能性が示唆される.


Kampo Medicine | 1992

A Study about the Correlation between Atherosclerosis and Diagonal Ear Lobe Crease. An evaluation of diagonal ear lobe crease as one of the clinical signs of Oketsu.

Yoji Kobayashi; Yoshihiro Fukuo; Akirou Terashi; Takurou Kanekawa

動脈硬化症や血栓症に伴う〓血状態の臨床的判定の一助として Diagonal Ear Lobe Crease (ELC) の有無判定が有用か否かを768名の健康診断受診者を対象に行った。その結果, ELC (+) 群において高血圧者や心電図異常者の頻度およびTC,β-Lp, Atherogenic Index などの血清脂質は有意に高く, Apo AI, Apo AI/B ratio は低値傾向, Apo AII は有意に低値であった。各種疾患で入院中の患者34例を対象に行った寺澤らの診断法による〓血度測定とELCの有無判測の結果, ELC (+) 群で有意に〓血度は高かった。以上の成績からELCと動脈硬化症は関連性が高いものと考えられ, 動脈硬化症や血栓症に伴う〓血の判定においてELCの有無判定を考慮して良いものと考えられた。動脈硬化症は未病の状態と考えられることから, ELC有無判定のような簡易な方法で〓血状態を臨床的に診断できることは有用であると思慮定れた。


Biomaterials, Artificial Cells and Immobilization Biotechnology | 1991

Long Term Effect of LDL Apheresis in Japan

Chikayuki Naito; Akira Yamamoto; Yasushi Saito; Eiji Muto; Toshio Nishide; Masaki Shinomiya; Mikio Mukai; Shoichi Tomono; Toshiya Sato; Kikuo Yasuda; Toshiaki Yamauchi; Hiroshi Mabuchi; Junji Kobayashi; Hitoshi Ueda; Kyohei Nonaka; Naruo Wada; Satoru Yamasak; Toshihiko Ono; Akira Yoshimura; Mariko Harada; Haruo Nakamura; Kazuo Kondo; Masato Ageta; Toshiharu Matsui; Hlroki Mayuyama; Yoshihiro Fukuo; Yuji Matsuzawa; Yasufumi Irie; Tadamasa Kon; Michinori Endo

LDL-apheresis is introduced in many cases all over Japan. Among them, evaluation of long-term effect on ischemic heart disease (IHD) has made on 10 cases with homozygous familial hypercholesterolemia (FH) and 49 cases with heterozygous FH.As to homozygous FH, 3 patients had angina pectoris. Mean duration of treatment was 26 months (52 treatments). The changes in total cholesterol (TC) in each treatment was from 426 mg/dl to 151 mg/dl. Improvement in IHD was observed in 5 out of 10 cases.As to heterozygous FH, 17 cases had history of myocardial infarction and 12 had angina pectoris. Mean duration of treatment was 13 months (19 treatments). Mean TC was decreased from 271 mg/dl to 126 mg/dl by each treatment. Regression in Achilles tendon thickenting or skin and palpebral xanthomas was observed. Frequency of anginal attacks decreased in 8 out of 17 cases. Ischemic change in ECG were improved in 3 out of 26 cases. Coronary angiography performed with 2 to 3 years of interval in some cases revealed regression o...


Japanese journal of geriatrics | 1985

[Studies on serum lipids and blood coagulation-fibrinolytic system in aged patients with old cerebral thrombosis].

Yoji Kobayashi; Yoshihiro Fukuo; Hitoshi Kato; Yoshihisa Nakazawa; Haruki Inaba; Toshimichi Shibuya; Kazumasa Hada; Hitoshi Yoshii; Akiro Terashi; Takuro Kanekawa

動脈硬化の発症, 進展や血栓症の要因として考えられている血清脂質代謝異常と血液凝固線溶異常の, 相互関係は多くの研究者により検討されている. しかし, 老年慢性期脳梗塞例, いわゆる寝たきり状態例についての報告は少ない. そこで著者らは, これら寝たきり老人 (平均76.4歳, 発作より平均1.4年経過したADL著しく不良例) 38例を対象として, 血清脂質 (TC, β1p, TRG, HDL C, Apo AI, Apo AII) および血液凝固線溶関連因子(Fbg, α1AT, α2M, ATIII, p1g, FDP, α2PI, FN, Factor XIII) を測定し次の結果を得た.1) 血清Apo AI, AII は患者群で有意に低値を示した.2) 血液Fbgは患者群で有意に高値, α1AT, α2M, P1g, ATIII, FDPは有意差なく, α2PI, FN, Factor XIIIは患者群で有意に低値を示した.3) 血清Apo AIとα2PIは患者群で有意の正相関を示した.4) 血清Apo AIとα2PIは, 対照群で有意の負の相関を示した.5) β1pとFNは患者群で有意の正相関を示した.6) FNとα2PIは患者群で有意の正相関を示した.以上の成績より, 老年慢性期脳梗塞例では動脈硬化の negative risk factor であるといわれているHDL Cの質的変化が生じており, また凝固線溶面の検討より, これらの症例では, 血栓形成促進傾向にあることが考えられ, 長期臥床状態では, 再発作への危険性が大である状態にあると考えられた.


Journal of Nippon Medical School | 1995

Effects of an HMG-CoA reductase inhibitor on cytokine production by human monocytes/macrophages

Yoshihiro Fukuo; Mikio Nagashima; Naoko Soya-Ohmura; Shinichi Takagi; Terashi Akiro; Takashi Ikejima


Biological & Pharmaceutical Bulletin | 1998

Cholesterol-Lowering Effects of Psyllium Seed Associated with Urea Metabolism

Kotaro Segawa; Tateshi Kataoka; Yoshihiro Fukuo


Journal of Nippon Medical School | 1996

A lipid lowering drug (bezafibrate) has a favorable effect on liver enzymes (Al-P and gamma-GTP).

Yoshihiro Fukuo; Toshiaki Kitami; Tatsuya Nomoto; Akiro Terashi


Journal of Nippon Medical School | 1994

Adhesion molecules in atherosclerosis

Yoshihiro Fukuo


The journal of Japan Atherosclerosis Society | 1992

The Influence of Sonic Stress on Lipid Metabolism and the Progress of Atherosclerosis in Rabbits with Hypercholesterolemia: -Studies on the Anti-atherosclerotic Effects of γ-Oryzanol in Sonic Stress-@@@―γ-オリザノールの抗動脈硬化作用―

Reibun Kanbara; Yoshihiro Fukuo; Kazumasa Hada; Takashi Hasegawa; Akiro Terashi

Collaboration


Dive into the Yoshihiro Fukuo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge